Oral Dextrose Formula in Performance of Soccer Athlete
- Disease/Condition
- Athletes
- Drug/Device/Intervention
- 10% Dextrose
- Study type
- Interventional
- Intervention type
- drug
- Primary sponsor
- Hasanuddin University
- Location
- Makasar, Indonesia
- Phase
- N/A
- Start date
- Mar 25, 2019
- End date
- Jun 30, 2019
- Enrollment
- 30 participants
Blood Glucose
I. Title of Proposed Research Project Dextrose 10% Drink Increase Blood Sugar and Sprint
 Velocity Compared to Sodium Dextrose in Soccer Players
 
 II. Specific Aims This study aims to evaluate the ergogenic effect in terms of blood sugar,
 VO2 max and sprint speed of dextrose 10% compared with sodium dextrose 10% in young male
 soccer players.
 
 III. Background Sports drinks are designed to provide CHO, electrolytes, and fluids to the
 body, which are absorbed very fast from the small intestine. In other words, the period from
 ingestion until the CHO, electrolytes, and fluids reach the muscles, brain and so on, should
 be very short. This is the most important advantage of using sports drinks (Simulescu, Ilia,
 Macarie, & Merghes, 2019). Commercial sports drinks generally contain both of CHO and sodium;
 To the best of the investigator's knowledge, there is no trial in which compare the
 differential effect of solely dextrose supplementation versus sodium dextrose in soccer
 players in terms of BG concentration, VO2 max and sprint speed, which may give a new paradigm
 for the available ergogenic sports drink.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT04206579
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT04206579 through Pure Global AI's free database. This phase not specified trial is sponsored by Hasanuddin University and is currently Completed. The study focuses on Athletes. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.